ArticleBone marrow transplantation2020

Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation.

T Caballero-Velázquez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.